Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02305758
Title Study Comparing Veliparib Plus FOLFIRI Versus Placebo Plus FOLFIRI With or Without Bevacizumab in Previously Untreated Metastatic Colorectal Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications

rectum adenocarcinoma

colon adenocarcinoma

Therapies

Fluorouracil + Irinotecan + Leucovorin

Bevacizumab

Veliparib

Age Groups: adult
Covered Countries


No variant requirements are available.